Advertisement

Topics

Alimera Sciences Company Profile

14:53 EDT 22nd June 2018 | BioPortfolio

Our name, Alimera, is a loose combination of ancient Greek words with the intended meaning of "Day of Truth" and is founded on the underlying principles of honesty, integrity, responsibility, candor, and trust. We recognize that everyday we have the opportunity to impact the lives of doctors, patients, partners, shareholders, family and friends and we understand the importance of these relationships. At Alimera Sciences, we believe in doing the right thing and knowing the right things to do. It is these qualities that shape Alimera Sciences' culture and that will ultimately benefit our corporate partners, our shareholders, and the customers we serve.
Mission
Alimera Sciences is a new kind of pharmaceutical company that's focused on doing the right thing and knowing the right things to do. Because of our deep industry experience, knowledge and relationships, we are able to rapidly bring forth meaningful products to eyecare. We approach all interactions with a win/win mindset and the goal of proving that an ethically-driven company can greatly impact value.

Location

6120 Windward Parkway, Suite 290
Alpharetta
Georgia
30005
United States of America

Contact

Phone: 678.990.5740
Fax: 678.990.5744


News Articles [592 Associated News Articles listed on BioPortfolio]

Investor Network: Alimera Sciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 1, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) will be discussing their earnings results in their Q4 Earnings Call to be held on March 1, 2018 at 9:00 AM Eastern ...

Alimera enters $40mm term loan with Solar Capital

Ophthalmic-focused Alimera Sciences Inc. entered into a $40mm million term loan agreement with Solar Capital. The loan matures on July 1, 2022, carries an interest rate of 9.2%, and is payable at one-...

Alimera refinances debt with $40 million agreement with Solar Capital

Alimera Sciences has entered into a $40 million term loan agreement with Solar Capital Ltd., according to a company press release.Alimera plans to use the loan to pay off an existing $35 million term ...

Alimera Sciences, Inc. 2018 Q1 - Results - Earnings Call Slides

Alimera Sciences reports $22 million annual net loss

Alimera Sciences reported a net loss of $7.2 million, or $0.10 per share, in the fourth quarter of 2017 compared with a net loss of $5.9 million, or $0.09 per share, in the same quarter the previous y...

Alimera Sciences to Present at the 38th Annual Cowen & Co. Health Care Conference

ATLANTA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today anno...

Alimera Sciences' (ALIM) CEO Dan Myers on Q1 2018 Results - Earnings Call Transcript

Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results

GAAP Net Loss cut by 34% from $33.2 in 2016 to $22.0 million in 2017Adjusted EBITDA loss reduced by 61% from $22.8 million in 2016 to $8.8 million 2017Filed for Type II variation for uveitis in Eur...

Clinical Trials [181 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1051 Associated Companies listed on BioPortfolio]

Alimera Sciences

Our name, Alimera, is a loose combination of ancient Greek words with the intended meaning of "Day of Truth" and is founded on the underlying principles of honesty, integrity, responsibility, candor, ...

Alimera Sciences, Inc.

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

T.A. Sciences

T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...

More Information about "Alimera Sciences" on BioPortfolio

We have published hundreds of Alimera Sciences news stories on BioPortfolio along with dozens of Alimera Sciences Clinical Trials and PubMed Articles about Alimera Sciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alimera Sciences Companies in our database. You can also find out about relevant Alimera Sciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record